CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT

por Matsuo, Tomohei, Iguchi‐Manaka, Akiko, Shibuya, Akira, Shibuya, Kazuko
Publicado 2022

Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells

por Okumura, Genki, Iguchi-Manaka, Akiko, Murata, Rikito, Yamashita-Kanemaru, Yumi, Shibuya, Akira, Shibuya, Kazuko
Publicado 2020

Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice

por Nagumo, Yoko, Iguchi-Manaka, Akiko, Yamashita-Kanemaru, Yumi, Abe, Fumie, Bernhardt, Günter, Shibuya, Akira, Shibuya, Kazuko
Publicado 2014

High expression of soluble CD155 in estrogen receptor-negative breast cancer

por Iguchi-Manaka, Akiko, Okumura, Genki, Ichioka, Emika, Kiyomatsu, Hiroko, Ikeda, Tatsuhiko, Bando, Hiroko, Shibuya, Akira, Shibuya, Kazuko
Publicado 2019

Accelerated tumor growth in mice deficient in DNAM-1 receptor

por Iguchi-Manaka, Akiko, Kai, Hirayasu, Yamashita, Yumi, Shibata, Kai, Tahara-Hanaoka, Satoko, Honda, Shin-ichiro, Yasui, Teruhito, Kikutani, Hitoshi, Shibuya, Kazuko, Shibuya, Akira
Publicado 2008

Increased Soluble CD155 in the Serum of Cancer Patients

por Iguchi-Manaka, Akiko, Okumura, Genki, Kojima, Hiroshi, Cho, Yukiko, Hirochika, Rei, Bando, Hiroko, Sato, Toyomi, Yoshikawa, Hiroyuki, Hara, Hisato, Shibuya, Akira, Shibuya, Kazuko
Publicado 2016